Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert PharmaceuticalfiledCriticalWarner Lambert Pharmaceutical
Publication of DK116436BpublicationCriticalpatent/DK116436B/da
C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
DK485663AA1962-10-161963-10-15Fremgangsmåde til fremstilling af 1-methyl-3-carboxy-6,7-dimethoxy-4-(1H)-quinolon eller salte heraf.
DK116436B
(da)